MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202617060403 A) filed by Centre National De La Recherche Scientifique; Institut Gustave Roussy; Universite Paris-Saclay; Institut National De La Sant Et De La Recherche; and Viroxis Number on May 12, 2026, for Oncolytic Viruses And Their Uses.
Inventors include Dupressoir, Anne; Tran, Ngoc Huong Giang; and Heidmann, Thierry.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: The invention concerns new oncolytic viruses and their uses In particular, the invention is a viral particle for its use in the prevention and/or the treatment of a tumor, said viral particle comprising: an inactivated nucleic acid sequence encoding the native envelope glycoprotein of the IROV encoded by said IROV genome; and a nucleic acid sequence encoding a retroviral envelope glycoprotein or a fragment thereof having a native targeting capacity for said host cell surface protein.
Disclaimer: Curated by HT Syndication.
